Jagsonpal Pharmaceuticals Live BSE/NSE | Jagsonpal Pharmaceuticals Fundamenta data | Jagsonpal Pharmaceuticals Balance sheet | Jagsonpal Pharmaceuticals Quarterly Results | Jagsonpal Pharmaceuticals Profit & Loss | Jagsonpal Pharmaceuticals Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

107.41
12.81
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

74.00
1.22%
1.02

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

-0.15
2.02
7.81

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-5.19
-6.30
-

PAT CAGR (%)

10 Years
5 Years
3 Years

0.92
19.35
-

P:E (Median)

8 Years
5 Years
3 Years

14.29
9.74
7.77

P:BV (Average)

8 Years
5 Years
3 Years

0.81
0.81
0.81

EV:EBITDA (Average)

8 Years
5 Years
3 Years

275.49
436.48
323.60

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 32 45 -30% 30 38 -23% 42 42 0% 42 44 -5%
Expenses 29 43 -33% 28 35 -19% 39 40 -1% 39 42 -6%
EBITDA 3 2 18% 1 3 -64% 3 2 16% 3 2 1%
EBIDTM 8% 5% 4% 9% 6% 5% 6% 6%
Other Income 1 1 16% 1 1 -14% 1 0 132% 0 0 144%
Interest 0 0 8% 0 0 -44% 0 0 0% 0 0 -25%
Depreciation 0 0 -3% 0 0 14% 0 0 13% 0 0 8%
PBT 3 2 21% 2 4 -59% 3 2 33% 3 2 15%
Tax 1 0 2% 0 1 - 1 0 42% 1 0 16%
PAT 3 2 26% 2 3 -48% 2 2 31% 2 2 15%
PATM 8% 4% 5% 8% 5% 4% 5% 4%
EPS 0.96 0.76 26% 0.59 1.14 -48% 0.87 0.67 30% 0.77 0.68 13%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 145 159 167 127 144 143 138 144 166 177 161 Net Sales Growth -15% -5% 32% -12% 0% 4% -4% -14% -6% 10% Cost Of Goods Sold 50 56 73 61 59 59 69 65 86 85 83 Gross Profit 95 102 94 65 85 84 69 79 80 92 78 GP Margin 65% 65% 56% 52% 59% 59% 50% 55% 48% 52% 48% Total Expenditure 136 150 157 138 138 132 129 133 156 160 146 Power & Fuel Cost - 1 1 1 2 2 2 2 3 3 2 % Of Sales - 0% 1% 1% 1% 2% 1% 2% 2% 1% 1% Employee Cost - 50 47 42 41 38 32 38 37 37 32 % Of Sales - 32% 28% 33% 28% 26% 23% 26% 22% 21% 20% Manufacturing Exp. - 0 1 1 1 2 1 2 2 1 2 % Of Sales - 0% 0% 1% 1% 1% 1% 1% 1% 1% 1% General & Admin Exp. - 20 19 16 16 14 10 9 9 9 8 % Of Sales - 13% 11% 13% 11% 9% 7% 6% 5% 5% 5% Selling & Distn. Exp. - 18 13 11 14 13 12 14 15 20 15 % Of Sales - 11% 8% 9% 10% 9% 8% 10% 9% 11% 9% Miscellaneous Exp. - 4 4 5 5 4 5 4 4 6 15 % Of Sales - 3% 2% 4% 3% 3% 3% 3% 2% 3% 3% EBITDA 9 9 9 -11 6 12 9 11 10 17 15 EBITDA Margin 6% 5% 6% -9% 4% 8% 6% 7% 6% 9% 9% Other Income 3 3 1 0 0 1 0 0 0 0 0 Interest 1 1 1 1 3 5 4 5 5 4 3 Depreciation 1 1 1 0 2 3 3 3 3 3 2 PBT 10 9 9 -12 2 4 2 3 3 10 9 Tax 2 2 2 0 3 1 0 0 1 3 2 Tax Rate 16% 16% 20% 1% 18% 20% 30% 16% 28% 26% 23% PAT 8 8 7 -12 12 3 1 2 2 7 7 PAT before Minority Interest 8 8 7 -12 12 3 1 2 2 7 7 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 6% 5% 4% -9% 8% 2% 1% 1% 1% 4% 4% PAT Growth -1% 9% 163% -197% 265% 178% -45% 16% -75% 4% EPS 3.20 3.00 2.76 -4.41 4.53 1.24 0.45 0.81 0.70 2.85 2.74

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

145

159

167

127

144

143

138

144

166

177

161

Net Sales Growth

-15%

-5%

32%

-12%

-4%

-14%

-6%

10%

Cost Of Goods Sold

Gross Profit

102

GP Margin

65%

56%

52%

59%

50%

55%

48%

52%

48%

Total Expenditure

136

150

157

138

132

129

133

156

160

146

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

32%

28%

33%

28%

26%

23%

26%

22%

21%

20%

Manufacturing Exp.

% Of Sales

General & Admin Exp.

% Of Sales

13%

11%

13%

11%

Selling & Distn. Exp.

% Of Sales

11%

10%

11%

Miscellaneous Exp.

% Of Sales

EBITDA

-11

EBITDA Margin

-9%

Other Income

Interest

Depreciation

PBT

-12

Tax

Tax Rate

16%

20%

18%

20%

30%

16%

28%

26%

23%

PAT

-12

PAT before Minority Interest

-12

Minority Interest

PAT Margin

-9%

PAT Growth

-1%

163%

-197%

265%

178%

-45%

16%

-75%

EPS

3.20

3.00

2.76

-4.41

4.53

1.24

0.45

0.81

0.70

2.85

2.74

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 111 104 98 110 98 95 99 98 98 93 Share Capital 13 13 13 13 13 13 13 13 13 13 Total Reserves 98 91 85 97 85 82 85 85 85 80 Non-Current Liabilities 3 3 3 3 4 4 4 4 4 4 Secured Loans 0 0 0 0 0 0 0 0 0 0 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 0 0 0 0 0 0 0 0 0 0 Current Liabilities 33 28 29 29 57 55 54 50 53 40 Trade Payables 12 12 9 9 10 8 5 7 8 5 Other Current Liabilities 8 6 6 7 7 6 5 4 5 3 Short Term Borrowings 5 4 8 8 38 39 36 33 35 28 Short Term Provisions 8 7 5 5 2 2 7 7 6 4 Total Liabilities 147 136 130 143 159 154 156 153 156 137 Net Block 22 22 21 22 52 52 56 58 59 58 Gross Block 56 55 54 53 90 88 87 86 83 79 Accumulated Depreciation 34 33 32 31 39 36 31 27 24 21 Non Current Assets 52 38 35 32 58 58 65 66 65 61 Capital Work in Progress 4 4 3 0 0 0 2 2 1 0 Non Current Investment 11 0 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 14 13 11 11 7 6 6 6 5 3 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 95 98 95 110 101 96 91 87 91 76 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 29 33 51 48 40 33 31 30 35 23 Sundry Debtors 21 21 25 39 42 45 45 42 42 43 Cash & Bank 38 39 15 20 16 15 13 10 10 7 Other Current Assets 6 1 0 0 4 3 3 4 4 3 Short Term Loans & Adv. 5 5 3 3 4 3 3 4 4 3 Net Current Assets 62 69 66 81 44 41 38 36 38 36 Total Assets 147 136 130 143 159 154 156 153 156 137

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

111

104

110

Share Capital

Total Reserves

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

147

136

130

143

159

154

156

153

156

137

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

110

101

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

Total Assets

147

136

130

143

159

154

156

153

156

137

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 11 31 -2 -3 9 4 8 12 7 5 PBT 9 9 -12 14 4 2 3 3 10 9 Adjustment -1 0 1 -9 8 7 8 8 7 5 Changes in Working Capital 4 20 9 -6 -2 -4 -3 2 -8 -7 Cash after chg. in Working capital 13 29 -2 0 10 5 8 13 9 7 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -2 2 0 -3 -1 0 -1 -1 -2 -2 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -11 -1 -3 41 -2 0 -1 -3 -5 -7 Net Fixed Assets -1 -2 -4 37 -3 2 -1 -4 -5 -7 Net Investments -11 0 0 0 0 0 0 0 0 0 Others 2 1 0 4 1 -2 0 0 0 0 Cash from Financing Activity -1 -6 -1 -34 -6 -1 -4 -8 0 3 Net Cash Inflow / Outflow 0 24 -6 5 1 2 2 0 3 2 Opening Cash & Equivalents 39 15 20 16 15 13 10 10 7 6 Closing Cash & Equivalent 38 39 15 20 16 15 13 10 10 7

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

-2

-3

PBT

-12

Adjustment

-1

-9

Changes in Working Capital

-6

-2

-4

-3

-8

-7

Cash after chg. in Working capital

-2

Interest Paid

Tax Paid

-2

-3

-1

-2

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-11

-1

-3

-2

-1

-3

-5

-7

Net Fixed Assets

-1

-2

-4

-3

-1

-4

-5

-7

Net Investments

-11

Others

-2

Cash from Financing Activity

-1

-6

-1

-34

-6

-1

-4

-8

Net Cash Inflow / Outflow

-6

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 39 37 34 39 35 33 33 33 33 30 ROA 6% 5% -8% 8% 2% 1% 1% 1% 5% 6% ROE 8% 8% -12% 12% 4% 1% 2% 2% 9% 9% ROCE 10% 10% -11% 14% 7% 5% 7% 6% 13% 12% Fixed Asset Turnover 2.86 3.07 2.38 2.03 1.62 1.59 1.68 2.01 2.22 2.19 Receivable days 49 50 93 102 110 118 110 91 86 89 Inventory Days 71 92 143 110 92 84 76 70 58 50 Payable days 34 32 27 22 21 15 10 12 11 13 Cash Conversion Cycle 86 110 209 190 180 186 176 148 134 126 Total Debt/Equity 0.05 0.04 0.09 0.08 0.43 0.45 0.42 0.39 0.41 0.36 Interest Cover 19 13 -17 6 2 1 1 1 3 4

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

ROA

-8%

ROE

-12%

12%

ROCE

10%

-11%

14%

13%

12%

Fixed Asset Turnover

2.86

3.07

2.38

2.03

1.62

1.59

1.68

2.01

2.22

2.19

Receivable days

102

110

118

110

Inventory Days

143

110

Payable days

Cash Conversion Cycle

110

209

190

180

186

176

148

134

126

Total Debt/Equity

0.05

0.04

0.09

0.08

0.43

0.45

0.42

0.39

0.41

0.36

Interest Cover

-17

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 507789 | NSE: JAGSNPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 507789 | NSE: JAGSNPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update